|
UPF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.731900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.114200E-01 |
| Normal-vs-Stage2 |
4.165400E-01 |
| Normal-vs-Stage3 |
7.018100E-04 |
| Normal-vs-Stage4 |
5.584800E-03 |
| Stage1-vs-Stage2 |
6.034800E-01 |
| Stage1-vs-Stage3 |
1.482140E-03 |
| Stage1-vs-Stage4 |
1.470160E-02 |
| Stage2-vs-Stage3 |
1.518980E-01 |
| Stage2-vs-Stage4 |
2.422600E-01 |
| Stage3-vs-Stage4 |
7.522800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.870500E-02 |
| Normal-vs-AfricanAmerican |
1.125990E-01 |
| Normal-vs-Asian |
3.722800E-01 |
| Caucasian-vs-AfricanAmerican |
6.999200E-01 |
| Caucasian-vs-Asian |
1.941810E-01 |
| AfricanAmerican-vs-Asian |
1.916250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.185600E-02 |
| Normal-vs-Female |
8.798300E-02 |
| Male-vs-Female |
8.533200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.107800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.148000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.060000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.406170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.373400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.586400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.874600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.215700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.547600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.375800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.840230E-03 |
| Normal-vs-Grade 2 |
9.934000E-01 |
| Normal-vs-Grade 3 |
1.883000E-03 |
| Normal-vs-Grade 4 |
1.845780E-04 |
| Grade 1-vs-Grade 2 |
1.389600E-02 |
| Grade 1-vs-Grade 3 |
1.57366999999908E-05 |
| Grade 1-vs-Grade 4 |
2.7696000000077E-06 |
| Grade 2-vs-Grade 3 |
1.218550E-04 |
| Grade 2-vs-Grade 4 |
5.56050000000141E-05 |
| Grade 3-vs-Grade 4 |
2.132200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.761800E-01 |
| Normal-vs-ccB subtype |
7.51680000000698E-05 |
| ccA subtype-vs-ccB subtype |
4.2831999946813E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.757800E-02 |
| Normal-vs-N1 |
1.365550E-01 |
| N0-vs-N1 |
7.140800E-01 |
|
|
